Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Cancer
|
October 28, 2020
Multivariate mortality analyses in COVID-19: Comparing patients with cancer and patients without cancer in Louisiana
Michael J Lunski, Jeffrey Burton, Karine Tawagi, et al.
ESMO Open
|
August 21, 2020
Gemcitabine/nab-paclitaxel with pamrevlumab: a novel drug combination and trial design for the treatment of locally advanced pancreatic cancer
Vincent Picozzi, Adnan Alseidi, Jordan Winter, et al.
Current Oncology (Toronto, Ont.)
|
June 25, 2026
Radiobiotherapy in Osteosarcoma: A State-Based Educational Framework for Strategy Selection and Trial Design
Srinivasan Vijayakumar, Shirley Lewis, Marc Matrana, et al.
The Oncologist
|
October 16, 2025
Pemigatinib for previously treated metastatic or unresectable central nervous system tumors with fibroblast growth factor receptor mutations or rearrangements: FIGHT-207 results
Iben Spanggaard, Marc Matrana, Caio Rocha Lima, et al.
Nature Communications
|
November 1, 2025
Real-world data and clinical experience from over 100,000 multi-cancer early detection tests
Marc Matrana, Vershalee Shukla, Dallas Kingsbury, et al.
Oncotarget
|
September 18, 2018
A patient-derived orthotopic xenograft model enabling human high-grade urothelial cell carcinoma of the bladder tumor implantation, growth, angiogenesis, and metastasis
Jessie Gills, Ravan Moret, Xin Zhang, et al.
Nature Reviews. Clinical Oncology
|
March 16, 2021
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
Aakash Desai, Justin F Gainor, Aparna Hegde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2020
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors
Sandip P Patel, Megan Othus, Young Kwang Chae, et al.
Nature Reviews. Clinical Oncology
|
March 24, 2021
Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
Aakash Desai, Justin F Gainor, Aparna Hegde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2022
Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial
Chung-Han Lee, Robert Motzer, Hamid Emamekhoo, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Cancer
|
October 28, 2020
Multivariate mortality analyses in COVID-19: Comparing patients with cancer and patients without cancer in Louisiana
Michael J Lunski, Jeffrey Burton, Karine Tawagi, et al.
ESMO Open
|
August 21, 2020
Gemcitabine/nab-paclitaxel with pamrevlumab: a novel drug combination and trial design for the treatment of locally advanced pancreatic cancer
Vincent Picozzi, Adnan Alseidi, Jordan Winter, et al.
Current Oncology (Toronto, Ont.)
|
June 25, 2026
Radiobiotherapy in Osteosarcoma: A State-Based Educational Framework for Strategy Selection and Trial Design
Srinivasan Vijayakumar, Shirley Lewis, Marc Matrana, et al.
The Oncologist
|
October 16, 2025
Pemigatinib for previously treated metastatic or unresectable central nervous system tumors with fibroblast growth factor receptor mutations or rearrangements: FIGHT-207 results
Iben Spanggaard, Marc Matrana, Caio Rocha Lima, et al.
Nature Communications
|
November 1, 2025
Real-world data and clinical experience from over 100,000 multi-cancer early detection tests
Marc Matrana, Vershalee Shukla, Dallas Kingsbury, et al.
Oncotarget
|
September 18, 2018
A patient-derived orthotopic xenograft model enabling human high-grade urothelial cell carcinoma of the bladder tumor implantation, growth, angiogenesis, and metastasis
Jessie Gills, Ravan Moret, Xin Zhang, et al.
Nature Reviews. Clinical Oncology
|
March 16, 2021
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
Aakash Desai, Justin F Gainor, Aparna Hegde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2020
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors
Sandip P Patel, Megan Othus, Young Kwang Chae, et al.
Nature Reviews. Clinical Oncology
|
March 24, 2021
Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
Aakash Desai, Justin F Gainor, Aparna Hegde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2022
Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial
Chung-Han Lee, Robert Motzer, Hamid Emamekhoo, et al.
Page
of 3